What is Cannabinoid Hyperemesis Syndrome (CHS)

Cannabinoid Hyperemesis Syndrome (CHS) is a condition first described in 2004 in Australia. Since then, it has attracted growing interest in both scientific research and public health discussions.

However, it is important to look at this syndrome carefully. Not all cannabis use leads to CHS. And not all cannabinoids appear to carry the same risk. In this article, we explain what CHS is, how it develops, what causes it, and what the research currently shows.

What Are Cannabinoids?

Cannabinoids are natural compounds found in cannabis plants. Researchers have identified at least 80 different cannabinoids so far. Many of them are the subject of ongoing scientific study.

The two most well-known cannabinoids are THC (tetrahydrocannabinol) and CBD (cannabidiol). But there are others, too — including CBG (cannabigerol), CBN (cannabinol), and CBC (cannabichromene). Each one has a different chemical profile and interacts with the body in different ways.

What Is Cannabinoid Hyperemesis Syndrome (CHS)?

CHS is an unpleasant condition that mainly affects people who use cannabis heavily over a long period. It typically appears after extended use and causes repeated nausea, vomiting, and stomach pain.

According to research, three key factors point to a CHS diagnosis. First, the person must have a history of long-term cannabis use. Second, episodes of nausea must follow a pattern that links clearly to cannabis use and last for weeks or months. Third, symptoms must stop within around ten days of stopping cannabis use.

The Phases of CHS

CHS tends to move through three phases. Understanding each one helps with early recognition and diagnosis.

The prodromal phase comes before the main symptoms start. It can be short or long. During this phase, people often experience morning nausea and general discomfort. Many continue to use cannabis at this stage because they do not yet connect the symptoms to their use.

The hyperemetic phase is when the main symptoms appear. This is the most difficult stage. It involves frequent vomiting, strong nausea, and stomach pain. Many people in this phase take frequent hot baths or showers. The heat seems to offer temporary relief from the abdominal pain — and this behaviour is now considered a notable sign of CHS. The length of this phase varies from person to person.

The recovery phase begins when the person stops using cannabis. In most cases, symptoms ease quickly after stopping — often within days. This pattern of relief is also a key part of the diagnosis.

The Endocannabinoid System (ECS)

To understand the causes of CHS, it helps to know how the endocannabinoid system works. The ECS is a network of receptors found throughout the human body. It plays a role in regulating sleep, appetite, digestion, mood, and many other functions.

The ECS has two main types of receptor: CB1 and CB2. CB1 receptors are found mainly in the brain and spinal cord. CB2 receptors appear more in the immune system and peripheral tissues.

The body makes its own molecules — called endocannabinoids — that bind to these receptors. Plant cannabinoids like THC can also bind to the same receptors. This is why cannabis has effects on the brain and body. But it is also why heavy, long-term use can disrupt how the ECS functions.

The Causes of CHS and Why It Is Hard to Diagnose

Current research points to THC as the main driver of CHS. THC binds directly to CB1 receptors in the ECS. With long-term, heavy use, this repeated activation seems to trigger a chain of reactions in the gut and brain that leads to the symptoms of CHS.

However, researchers still do not fully understand the exact mechanism. Genetic factors may also play a role, but their contribution is not yet clear in the scientific literature.

CHS is also hard to diagnose. Its symptoms — nausea, vomiting, and stomach pain — overlap with many other digestive conditions. Because of this, CHS is often missed or misdiagnosed. The clearest diagnostic clue is the pattern: symptoms that appear with heavy cannabis use and stop when use ends.

Can All Cannabis Products Cause CHS?

Based on current research, the answer is probably no. THC appears to be the key factor in CHS. It is the cannabinoid most consistently linked to the condition across studies and patient cases.

Other cannabinoids — including CBD and CBG — do not bind to CB1 receptors in the same way as THC. Research into their role in CHS is limited, but so far there is no strong evidence linking CBD or CBG to CHS development.

However, more research is needed. And it is always a good idea to speak with a healthcare professional before using any cannabis product — especially with regular or long-term use in mind.

CBD Products From Canna Health Amsterdam

Here at Canna Health Amsterdam, we sell CBD products that contain no THC. If you are curious about cannabinoids but want to avoid THC, these are worth exploring:

• CBD Gummies (banana flavour) — A simple, easy way to take CBD daily. No THC.
• CBD Gummies (watermelon flavour) — Same formula, different flavour. Popular and consistent.

These products are not medicines and are not intended to diagnose, treat, cure, or prevent any condition. If you have any health concerns, always consult a qualified healthcare professional first.

Conclusion

Cannabinoid Hyperemesis Syndrome is a real and documented condition. But it is linked specifically to long-term, heavy THC use — not to cannabis as a whole, and not to all cannabinoids.

If you experience repeated nausea, vomiting, or stomach pain alongside regular cannabis use, speak to a doctor. Early recognition of CHS makes it easier to manage. And stopping cannabis use remains the most effective way to resolve symptoms.

As always, understanding what you are using and why is the best starting point.

Disclaimer: This blog is for informational and educational purposes only. We review and reference available studies and reputable sources; however, content may not reflect the most current research or regulations and should not be taken as medical, legal, or professional advice. We do not make or imply health claims. Products mentioned are not intended to diagnose, treat, cure, or prevent any disease and statements have not been evaluated by EFSA or the FDA. Effects can vary between individuals. Always consult a qualified healthcare professional before use and verify that any product or ingredient is lawful in your jurisdiction.